CytomX Therapeutics, Inc. (CTMX) Analyst Forecast

NASDAQ Currency in USD Disclaimer

Add to Alerts ADD TO LIST

south_east

-$0.01 (-0.84%)

Day's range

$0.82

$0.86

Date	Brokerage Firm	Analyst Name	Price Target	Price when Posted	Upside/Downside on Report Date
11/08/2024	BMO Capital	Etzer Darout	$3.68	$1.09	237.61%
11/08/2024	Piper Sandler	Joseph Catanzaro	$3.25	$1.09	198.17%
08/09/2024	BMO Capital	Etzer Darout	$3.56	$1.18	201.69%
05/27/2024	Piper Sandler	Joseph Catanzaro	$3.50	$1.75	100%
05/09/2024	BMO Capital	Etzer Darout	$3.59	$4.19	-14.32%
05/09/2024	Wedbush	Robert Driscoll	$8.00	$2.40	233.46%
05/05/2024	Jefferies	Roger Song	$8.00	$4.46	79.57%
03/12/2024	Jefferies	Roger Song	$2.50	$2.15	16.28%
03/12/2024	BMO Capital	Etzer Darout	$3.25	$2.15	51.16%

CytomX Therapeutics, Inc. FAQ's

What analysts cover CytomX Therapeutics, Inc.?

CytomX Therapeutics, Inc. has been rated by research analysts at BMO Capital, Piper Sandler, Wedbush, Jefferies in the past 90 days.